ZIP4 silencing improves bone loss in pancreatic cancer

Metabolic bone disorders are associated with several types of human cancers. Pancreatic cancer patients usually suffer from severe nutrition deficiency, muscle wasting, and loss of bone mass. We have previously found that silencing of a zinc transporter ZIP4 prolongs the survival and reduces the sev...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qiang, Sun, Xiaotian, Yang, Jingxuan, Ding, Hao, LeBrun, Drake, Ding, Kai, Houchen, Courtney W., Postier, Russell G., Ambrose, Catherine G., Li, Zhaoshen, Bi, Xiaohong, Li, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694884/
https://www.ncbi.nlm.nih.gov/pubmed/26305676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694884/
https://www.ncbi.nlm.nih.gov/pubmed/26305676

Ejemplares similares